News & Financial Highlights >
Report Monitor

Below is a list of recently released reports on biotechnology, covering issues ranging from safety to the industry's role economic development.

Sep. 2002 U.S. Government Accounting Office testimony before the Subcommittee on Public Health, Committee on Health, Education, Labor, and Pensions, U.S. Senate: Childhood Vaccines: Challenges in Preventing Future Shortages www.bio.org/investor/report/GAOReportonVaccines9-20021.pdf (70 KB PDF)
 
Sep. 2002
Integrating Intellectual Property Rights and Development Policy
 At the behest of the British Government, the Commission on Intellectual Property has produced Integrating Intellectual Property Rights and Development Policy, a study exploring the rationale for the current global patent system the impact of that system in a variety of industrial sectors, including agriculture and health. www.iprcommission.org/graphic/documents/final_report.htm
 
Sep. 2002
 University of Toronto Joint Centre for Bioethics: "Top 10 Biotechnologies for Improving Health in Developing Countries." An international panel of experts identifies 10 genomic and other biotechnologies with the greatest potential for improving global health within a decade, particularly in the world's poorer counties. A free online version is available at www.utoronto.ca/jcb/_genomics/top10biotechnologies.pdf (PDF); a paperback version is also available for sale online or by calling (888) 624-8373.
 
Sep. 2002
100 Years of Bacillus thuringiensis (Bt)
 American Academy of Microbiology: "100 Years of Bacillus thuringiensis (Bt): A Critical Scientific Assessment." This report highlights as a case study Bt and its use in agriculture, as well as addressing the current controversy, benefits and potential risks associated with transgenic plants. Free online version is available at www.asmusa.org/acasrc/aca1.htm#Bt%20Availability.
 
Sep. 2002
Butterflies and Bt Corn: Allowing Science to Guide Decisions
 USDA Agricultural Research Service and a group of university and organizations: "Butterflies and Bt Corn: Allowing Science to Guide Decisions." A brochure chronicling the monarch butterfly and Bt corn controversy and how the conclusion was reached that Bt corn pollen does not pose a risk to monarch populations. The brochure is available at www.ars.usda.gov/sites/monarch.
 
Aug. 2002 National Academies of Science: "Animal Biotechnology: Science-Based Concerns." The report takes a scientific look at the use and introduction of animal biotechnology for food and protein production. A free online version is available at www.nap.edu/catalog/10418.html?onpi_newsdoc082002002; a paperback version is also available for sale online or by calling (888) 624-8373.
 
Aug. 2002 Time Magazine: "The Green Century." A special report in the Aug. 26 edition discussing ways to transform industry, timed to coincide with the World Summit on Sustainable Development in Johannesburg, South Africa. Available online for subscribers or for a fee at www.time.com.
 
July 2002
Generic Drug Entry Prior to Patent Expiration
 Federal Trade Commission: "Generic Drug Entry Prior to Patent Expiration." A report recommending legislative action designed to ensure that two provisions of the Hatch-Waxman amendments do not delay generic drug entry to market. The commission's recommendations would permit only one 30-month stay on the entry of a generic drug during pending patent-infringement litigation and would support new legislation to require brand-name companies and initial generic applicants to provide copies of certain agreements to the FTC and the Department of Justice for review. A pdf version of the report is available at www.ftc.gov/os/2002/07/genericdrugstudy.pdf (PDF).
 
June 2002
Beyond Borders: The Global Biotechnology Report 2002
 In Beyond Borders: The Global Biotechnology Report 2002, Ernst & Young surveys the worldwide biotechnology landscape, providing statistics on biotech activity in every major region, as well articles on trends. The executive summary can be read online and the complete report may be purchased at www.ey.com/global/content.nsf/International/Health_Sciences_-_Beyond_Borders.
 
June 2002
Signs of Life: The Growth of Biotechnology Centers in the U.S.
 The Brookings Institution, Center on Urban and Metropolitan Policy: "Signs of Life: The Growth of Biotechnology Centers in the U.S." This report analyzes biotechnology activity in the 51 largest U.S. metropolitan areas and finds that the industry is heavily concentrated in nine regions; Boston, Los Angeles, New York, Philadelphia, Raleigh-Durham, San Diego, San Francisco, Seattle, and Washington-Baltimore. The report can be found online at www.brookings.org/dybdocroot/urban/publications/biotech.htm.